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To rejuvenate tissues and/or repair wounds, stem cells must receive extrinsic signals from their surrounding
environment and integrate them with their intrinsic abilities to self-renew and differentiate to make tissues.
Increasing evidence suggests that the superfamily of transforming growth factor-bs (TGF-bs) constitute
integral components in the intercellular crosstalk between stem cells and their microenvironment. In this
review, we summarize recent advances in our understanding of TGF-b superfamily functions in embryonic
and adult stem cells. We discuss how these pathways help to define the physiological environment where
stem cells reside, and how perturbations in the signaling circuitry contribute to cancers.Introduction
A single fertilized egg gives rise to all the cell types in the body.
As individual tissues form, they set aside reservoirs (niches) of
stem cells that become more restricted in their lineage options.
These fascinating cells are long-lived and their purpose is to
make and replenish the differentiated cells within their resident
tissues that are lost through normal stress and injury. Stem cells
also have the remarkable property to replenish themselves,
a process known as self-renewal. Although this is not a universal
feature, many stem cells are used sparingly, often giving rise to
rapidly proliferating but transient cells that perform the lion’s
share of tissue regeneration. Stem cells that spend much of their
time in a quiescent state are protected from unnecessary cell
divisions that can lead to cancer.
Stem cell niches must be dynamic to enable stem cells to
respond promptly to tissue demands (Hsu and Fuchs, 2012).
Stem cells that receive signals from their surrounding environ-
ment galvanize intracellular transduction pathways, which
deliver information to the genome in the form of activated tran-
scription factors. These factors recognize specific sequence
motifs in the genome, where they associate with different tran-
scription factors, coactivators, and chromatin remodelers to
exert their effects. This combinatorial action of intrinsic and
extrinsic factors allows for the same signaling pathways to be
used in multiple cellular environments and elicit a diverse array
of responses (Massague´ and Xi, 2012).
Signaling by the transforming growth factor-b (TGF-b) super-
family features prominently in embryonic development, tissue
homeostasis and regeneration, immune responses, tumor
suppression, and metastasis (Li and Flavell, 2008; Massague´,
2008; Derynck and Miyazono, 2008; Wu and Hill, 2009). Not
surprisingly, these factors also govern the behaviors of many
stem cell populations. TGF-b factors are secreted, and depend-
ing upon cell type, context, ligand expression, and dosage, they
can exert pleiotropic and sometimes opposing cellular effects
that include proliferation, differentiation, migration, and death.
In addition to three TGF-bs (TGF-b1–3), the superfamily includes
bonemorphogenetic proteins (BMPs), growth and differentiation
factors (GDFs), anti-Mu¨llerian hormone (AMH), Activins, and
Nodal. Many family members and their downstream pathway
components are well-conserved across metazoan evolution,and indeed, BMPs and Nodal-type ligands are found in both
vertebrates and invertebrates. An exception could be the super-
family’s namesakes, vertebrate TGF-b 1–3, which do not appear
to have counterparts in nematodes (C. elegans) or insects
(Drosophila) (Lapraz et al., 2006).
The TGF-b superfamily members are intriguing in that their
activities are controlled at multiple levels. All are translated as
larger polypeptides whose amino-terminal prodomains are
required for their proper folding and dimerization (Gray and
Mason, 1990). Even though cleavage by a furin-like protease
occurs intracellularly, noncovalent association between TGF-
bs and their prodomains persists after secretion. For some
TGF-b superfamily members, like TGF-b 1–3, BMP10, and
GDF-8/myostatin, their prodomains (latency associated pro-
teins, or LAPs) render them inactive and orchestrate their
association with other inhibitory, latent TGF binding proteins
(LTBPs). In these cases, the prodomains are sufficient to confer
latency, while LTBPs target the complex to extracellular matrix
(ECM) components such as fibrillins (Munger and Sheppard,
2011). For BMP4, 5, and 7 and some other processed family
members, however, prodomain association does not affect
activity (Sengle et al., 2011).
Biochemical studies have often used TGF-b1 as a paradigm.
Although TGF-b1 synthesis and expression of its receptors
occur in many cells, activation is typically paracrine and
restricted to sites where TGF-b1 is released from latency
(Figure 1). TGF-b1 activation has been shown to be influenced
by plasmin, matrix metalloproteinases, thrombospondin-1, pH,
and reactive oxygen species (Annes et al., 2003). However,
TGF-b1 activation can also be controlled by certain integrins
that can bind to the Arg-Gly-Asp (RGD) sequence within LAPs,
resulting in a force-dependent conformational change that frees
the active form from its prodomain (Munger et al., 1999; Shi et al.,
2011). For the entire superfamily, a large repertoire of soluble
extracellular agonists and antagonists within tissues provide
further complexity in regulating ligand access to their receptors
(Derynck and Miyazono, 2008).
Active TGF-b ligands signal by binding and bringing together
two transmembrane serine-threonine kinases, known as
receptor types I and II (Derynck, 1994) (Figure 1). In vertebrates,
there are seven type I receptors [Activin-receptor like kinasesCell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc. 751
Figure 1. Canonical Signaling Pathways of TGF-b Superfamily
When TGF-b propeptides are processed, the ligand associates noncovalently
with the processed peptide. For some ligands, including the classical TGF-bs,
activity is blocked by the peptide, and hence has been given the term latency
associated peptide (LAP). LAPs can bind to latent TGF-b binding proteins
(LTBPs) and other proteins within the extracellular matrix (ECM), and various
activation mechanisms (dashed arrow) are then needed to extricate them from
the ligand. Once liberated, ligands bind to specific combinations of type I and
type II receptor serine-threonine kinases. In the ligand-receptor complexes,
type II receptors phosphorylate and activate type I receptors, which in turn
phosphorylate R-Smads and initiate intracellular signaling. R-Smad activation
bifurcates the superfamily into two major branches: TGF-bs, Activins, and
Nodal primarily use Smad2 and 3; and BMPs and GDFs use Smad1, 5, and 8.
Inhibitory Smads (Smad6 and 7) function by blocking type-I-receptor-medi-
ated phosphorylation of Smad1/5/8 (Smad6) or both Smad2/3 and Smad1/5/8
(Smad7). Once phosphorylated, R-Smads couple with co-Smad (Smad4) and
translocate to the nucleus to act as a bipartite transcription factor. Generally,
R-Smad-Smad4 transcription complexes have weak affinities to DNA and
hence bind to other transcription factors for stable and specific binding to gene
enhancers/promoters. R-Smad-Smad4 also associates with transcription
coregulators, chromatin modifiers, and other chromatin remodelers.
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Superfamily ligands bind to and signal through specific type I and
type II receptor complexes. Upon ligand activation, a type II
receptor phosphorylates its type I receptor partner, which then
propagates the signal by phosphorylating intracellular down-
stream substrates. The key canonical effectors are regulatory
R-Smads 1, 2, 3, 5, and 8. Smad2/3 become phosphorylated
by ALK4/5/7 upon TGF-b, Nodal, or Activin signaling. By
contrast, Smad1/5/8 are typically phosphorylated by ALK1/2/
3/6, downstream of BMP or GDF signaling, although some
GDFs, such as GDF-8/myostatin and GDF-11, function through
Smad2/3, not Smad1/5/8. Inhibitory Smads (I-Smads: Smad6
and 7) can interfere with both of these branches by directly
binding to R-Smads and blocking their modification (Figure 1).
Once phosphorylated, R-Smads can complex with a common
mediator Smad (co-Smad: Smad4), translocate to the nucleus,
and form an active bipartite transcription factor. Smads require
chromatin to assemble the basal transcription machinery, and
thus are thought to affect transcription through modulation of
chromatin structure (Ross et al., 2006). They can either activate
or repress transcription through their interactions with chro-752 Cell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc.matin-modifying coactivators such as p300/CBP histone
acetyl-transferases (HATs) or corepressors such as histone
deacetylases (HDACs) or ATPases of the SWI/SNF chromatin-
remodeling complex (Ross and Hill, 2008). Adding diversity to
their transcriptional responses are their distinctive DNA
sequence specificities. Complexes of Smad4 and activated
(phosphorylated) Smad2/3 bind to AGAC or its complement
GTCT, known as a Smad-binding element (SBE) (Dennler
et al., 1998; Zawel et al., 1998), whereas Smad4-pSmad1/5/8
complexes preferentially bind to GGCGCC or GGAGCC, which
is also known as the BMP-response element (BRE) (Katagiri
et al., 2002; Korchynskyi and ten Dijke, 2002; Morikawa
et al., 2011).
While the majority of TGF-b signaling routes go through
phosphorylated R-Smads, not all responses involve Smad4.
An interesting case in point is the catalytic subunit of a well-
known transactivator of nuclear factor kB (NF-kB), IkB kinase
(IKKa). In cultured epidermal keratinocytes, IKKa recruits
pSmad2/3 to a specific promoter region and drives differentia-
tion (Descargues et al., 2008). A Smad4-independent role for
pR-Smads has also been implicated in microRNA maturation
in the nucleus (Davis et al., 2008).
While less understood, pR-Smad-independent TGF-b sig-
naling pathways have also been identified. One is E3 ligase
TNF receptor-associated factor 6 (TRAF6), which can be acti-
vated directly by TGF-b receptor signaling. TRAF6 then modifies
and activates TGF-b activated kinase-1 (TAK1), which can acti-
vate various kinases to elicit a diverse array of context-depen-
dent responses (Sorrentino et al., 2008; Yamashita et al.,
2008). Activated TGF-b receptors can also phosphorylate Shc,
thereby recruiting Grb and Sos to the membrane, activating
Ras GTPase and ERK MAPK signaling (Lee et al., 2007).
Ligand-activated type II receptor TbRII can even signal indepen-
dently of TbRI. One of its targets is Par6, which when phosphor-
ylated, can spark events resembling an epithelial-mesenchymal
transition (EMT) (Ozdamar et al., 2005). TGF-b1 signaling can
also affect actin dynamics by activating the small GTPase
RhoA (Bhowmick et al., 2001), and also Pak2 kinase, normally
downstream of Cdc42 and Rac1 (Wilkes et al., 2003).
Endowed with the capacity to trigger such a remarkable
cornucopia of downstream signaling pathways and cellular
responses, it is no surprise that TGF-b superfamily members
are potent morphogens in development. Their roles begin early,
when positional information first specifies endoderm, meso-
derm, and ectoderm (Zorn and Wells, 2007) and then patterns
the body axes (DeRobertis and Kuroda, 2004; Schier and Talbot,
2005). Their involvement continues during embryogenesis as
tissues and organs form. The TGF-b superfamily also functions
in maintaining tissue homeostasis and regeneration, which are
the life-sustaining features that are fueled by adult stem cells.
The challenge for researchers is to understand the extrinsic
and intrinsic factors that dictate how such signaling will influence
a stem cell in its niche, and how these processes go awry in
human disorders such as cancers and metastases, where
TGF-b signaling pathways are known to be deregulated. By
examining and comparing TGF-b superfamily signaling in
different stem cell populations, glimpses as to how this might
happen start to emerge. In this review, we witness elaborate
molecular machineries that are built upon orchestrated crosstalk
Figure 2. Signaling Crosstalk between TGF-b andOther Pathways in
Mouse and Human ESCs
(A) Self-renewal mechanisms in mouse ESCs. LIF and BMPs cooperate to
maintain self-renewal. Tyrosine kinase receptor signaling, e.g., FGFs, typically
activate downstream effectors ERK-MAPK, and induce differentiation. BMPs
induce canonical Smad1/5/8 signaling pathways and one of their key targets
for ESCs was recently shown to be the gene encoding ERK-specific phos-
phatase Dusp9. Dusp9 negatively affects ERK activity and hence supports
ESC self-renewal. Through the simultaneous induction of another BMP target
gene, Id, and through activation of the STAT3 pathway by LIF, these two
factors further promote ESC self-renewal by inhibiting neuroectoderm and
mesendoderm differentiation, respectively.
(B) Self-renewal mechanisms in human ESCs. Nodal/Activin and hyperactive
PI3K/Akt signaling cooperate to maintain self-renewal. Nodal/Activin induce
canonical Smad2/3 signaling pathways and a key target for ESCs is Nanog.
Hyperactive PI3K/Akt signaling can be achieved by some growth factors,
such as FGF and IGFs, and this leads to suppression of ERK activity. When
PI3K/Akt signaling diminishes, ERK inhibition is relieved, which in turn
suppresses the GSK3b kinase. This results in stabilization of b-catenin, which
apparently associates with pSmad2/3-Smad4 to influence the target genes
that become transcribed, thereby switching the ESC from a self-renewing to
differentiating status.
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specific, context-dependent roles of TGF-b superfamily
members.
TGF-b Superfamily Signaling in Embryonic Stem Cells
Roles of TGF-b Superfamily in Self-Renewal and
Pluripotency
Embryonic stem cells (ESCs) are pluripotent cells, initially
derived from the inner cell mass (ICM) of mouse blastocyst
embryos and grown as a cell line in tissue culture. While mouse
ESCs (mESCs) provide a crucial tool for manipulating embryos to
study mouse genetics, development, and physiology (Evans,
2011), human ESCs (hESCs) hold promise for regenerative
medicine (Thomson et al., 1998). However, hESCs appear to
have been derived from a later developmental stage thanmESCs
(Tesar et al., 2007; Brons et al., 2007). Thus, caution must be
exercised in comparing data from mouse and human for either
ESCs or induced pluripotent stem cells (iPSCs), which are
ESC-like cells derived from genetic manipulation of adult tissue
cells (Takahashi and Yamanaka, 2006).
Whether mouse or human, ESCs are remarkable for their
capacity to be maintained and propagated in vitro, where they
can be differentiated to form a myriad of cell types (Smith,
2001; Murry and Keller, 2008). ESC fate decisions and mainte-
nance are controlled by both intrinsic and extrinsic factors. Inter-
nally, epigenetic processes such as DNA methylation and
histone modifications contribute to ESC fate determination
(Christophersen and Helin, 2010), while core transcription
factors, including Tcf3, Nanog, Oct4, and Sox2, form autoregu-
latory circuits that maintain self-renewal and pluripotency (Boyer
et al., 2005; Chen et al., 2008; Kim et al., 2008). Externally, how-
ever, mESCs and hESCs rely on different signaling pathways to
self-renew and maintain pluripotency. mESCs rely on leukemia
inhibitory factor (LIF) and BMP signaling (Smith, 2001; Qi et al.,
2004), whereas hESCs rely on fibroblast growth factor (FGF)
and Nodal/Activin signaling (Besser, 2004; Vallier et al., 2005).
At least for mESCs, BMP and LIF combined alleviate the need
for serum and feeder cells (Ying et al., 2003). Specific small mole-
cule inhibitors of ERK and the GSK3b kinase (2i conditions) yield
a similar outcome, indicating that under conditions where ERK
levels are low, silencing GSK3b activity may be able to substitute
for activating STAT3 (Ying et al., 2008). Analogously, serum-free
defined medium supplemented with TGF-b1 or Nodal and FGF2
on a vitronectin substrate can sustain in vitro growth of both
hESCs and hiPSCs (Chen et al., 2011).
Although mESC fate decisions are influenced by external
BMP/LIF and internal ERK activity, the details of these intercon-
nections are still unfolding. Recently, Chen and colleagues
demonstrated that BMP4 is required to significantly inhibit ERK
activity (Li et al., 2012), which is consistent with a previous report
(Qi et al., 2004). Digging deeper into the mechanism, the authors
provided evidence that BMP4 may exert these effects directly
through canonical pSmad1/5-Smad4 activation of the gene en-
coding ERK-specific dual-specificity phosphatase 9 (Dusp9).
Underscoring the physiological relevance of these findings,
Dusp9 is expressed in E3.5 embryos of wild-type, but not
Smad4/, mice. Moreover, in vitro, Dusp9 knockdown uncou-
ples BMP’s braking power on ERK, resulting in enhanced ERK
phosphorylation/activation and decreased ESC self-renewal.Conversely, Dusp9 overexpression mimics BMP signaling to
dampen ERK activity and sustain mESC self-renewal (Li et al.,
2012). Together, these findings make a compelling case for
Dusp9 as an essential BMP4 mediator of ERK inhibition in the
natural process of mESC self-renewal (Figure 2A).
An enigma is that BMP has opposite effects on hESC
fate control, where it represses self-renewal and promotesCell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc. 753
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regard, two points are noteworthy. First, as classical morpho-
gens, BMPs and Nodals are known to elicit different develop-
mental outcomes depending upon concentration. Second, the
developmental differences between mESCs and hESCs could
affect their differential responses.
Roles of TGF-b Superfamily in Balancing ESC Self-
Renewal and Differentiation
During embryogenesis, progenitors respond to temporally well-
defined regiments of morphogens that activate transcriptional
networks and progressively seal cell fates. In many cases,
including those involving TGF-b superfamily members, ERKs,
and canonical Wnts, the morphogens and signaling pathways
that function in promoting lineage specification and differentia-
tion are the same ones that are essential for the maintenance
or self-renewal of cultured ESCs (McLean et al., 2007; Sumi
et al., 2008). In the past few years, researchers have begun to
uncover how relative activities of common signaling pathways
can be recapitulated in vitro to determine whether ESCs should
self-renew or differentiate.
Nodal/Activin signaling is critical for self-renewal and pluripo-
tency of both hESCs and mESCs, where it leads to nuclear
appearance of pSmad2/3 and transactivation of the key pluripo-
tency gene Nanog (Xu et al., 2008; Vallier et al., 2009). Moreover,
mouse epiblasts lacking either Nodal or Smad2/3 are unusually
small and express very little Oct4 (Conlon et al., 1994; Dunn
et al., 2004). Analogously, treatment of hESCs with the Nodal
receptor kinase inhibitor SB431542 results in decreased expres-
sion of pluripotency genes (Jameset al., 2005; Vallier et al., 2005).
In hESCs, Nodal/pSmad2/3 signaling and GSK3b inhibition are
sufficient to maintain the undifferentiated state (Besser, 2004).
Thus, although the underlyingmechanismsmight differ in details,
TGF-b superfamily signaling in ESCs converges squarely in the
stream of events that reinforce self-renewal and pluripotency.
Despite its crucial role in ESC pluripotency, Nodal/Activin
signaling also functions in vitro and in vivo to drive differentiation
of pluripotent stem cells toward mesendoderm, the common
progenitor of definitive mesoderm and endoderm lineages
(D’Amour et al., 2005; Arnold and Robertson, 2009). Studying
hESCs, Vallier and colleagues recently reported how Nodal/Ac-
tivin signalingmightmaintain pluripotency without inducingmes-
endoderm differentiation (Chng et al., 2010). They identified
Smad-interacting protein 1 (SIP1) as a strongly upregulated
gene upon SB431542-mediated inhibition of Nodal/Activin.
When Nodal/Activin signaling is active, Smad2/3 together
with Nanog and Oct4 repress SIP1 expression. When Nodal/
Activin signaling is dampened, elevated SIP1 further suppresses
residual Nodal/Activin, thereby diminishing the mesendoderm-
inducing effects of Nodal/Activin and BMP signaling. These
changes favor the neuroectodermal ‘‘default’’ pathway (Camus
et al., 2006), which is consistent with the finding that the syner-
gistic action of BMP inhibitor (Noggin) and Nodal/Activin/TGF-
b inhibitor (SB431542) is sufficient to induce neural induction in
hESCs and iPSCs (Chambers et al., 2009). This model reveals
how extracellular signals can cooperate with the core pluripo-
tency transcriptional network to balance neuroectoderm and
mesendoderm differentiation.
A recent study on hESCs by Dalton and colleagues provides
a curious example of how this decision can be affected by754 Cell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc.complex crosstalk between Nodal/Activin/Smad2/3, MAPK/
ERK, and canonical Wnt/GSK3b/b-catenin pathways (Singh
et al., 2012). They show that certain growth factors such as
Fgf2 or Igf1/heregulin superactivate PI3K/Akt, and this leads
to paradoxical suppression rather than enhancement of ERK
activity. Such growth factors can thus act in conjunction with
Nodal/Activin/Smad2/3/Nanog signaling to maintain self-
renewal (Figure 2B, left). Conversely, reducing PI3K/Akt in
ESCs exposed to Nodal favors mesendoderm differentiation
(Figure 2B, right). At first glance, the effects of Nodal and PI3K
on pluripotency seem similar to those on BMP4 and ERK
suppression. However, the results differ in that robust PI3K/Akt
elevates rather than suppresses GSK3b kinase levels, and in
the face of active canonical Wnt/b-catenin signaling, Nodal/
Activin induces genes that drive mesendoderm differentiation.
Typically, self-renewal is favored when GSK3b activity is sup-
pressed, because it leads to enhanced stabilization of b-catenin,
a key transcriptional cofactor of the canonical Wnt signaling
pathway (Besser, 2004; Ying et al., 2008; ten Berge et al.,
2011; Wray et al., 2011). Given the crosstalk between TGF-b
superfamily and Wnt signaling pathways and the powerful
effects of both pathways on self-renewal and differentiation, it
is increasingly apparent that the combinatorial activities of other
signaling pathways can dictate different outcomes.
Transcriptional Networks Downstream of TGF-b
Superfamily Signaling
Recent genome-wide analyses of Smad proteins bound to chro-
matin have greatly advanced our understanding of TGF-b super-
family signaling. On their own, Smads bind with low affinity to
DNA, and require interactions with other transcription factors
to stabilize their binding to chromatin (Ross and Hill, 2008). In
ESCs, Oct4, Sox2, and Nanog bind to a number of key pluripo-
tency genes (Takahashi and Yamanaka, 2006; Graf and Enver,
2009). Interestingly, in response to BMP signaling, Smad1 (pre-
sumably with Smad4) binds to and regulates many of the plurip-
otency genes targeted by the Oct4/Nanog/Sox2 transcriptional
complex (Chen et al., 2008). Similarly, in response to Nodal/
Activin signaling, Smad3 (presumably with Smad4) forms a phys-
ical complex with Oct4 and directly regulates many of the same
genes bound by Oct4 (Mullen et al., 2011). Additionally, Oct4
deficiency causes a dramatic reduction in Smad3 occupancy
across the genome, and genes normally co-occupied by Oct4
and Smad3 lose their responsiveness to Nodal/Activin signaling.
Since in ESCs, key pluripotency genes have a more open
chromatin state, the ability of ESC master regulators to recruit
pSmad3-Smad4 may also facilitate the weaker binding
pSmad3-Smad4 complexes to recognize and bind to their
cognate binding elements.
Another intriguing facet is that depending upon the cell type
and its associated master regulators, Smad3 changes its reper-
toire of interacting partners and target genes. Thus, in myotubes,
Smad3 co-occupies sites with Myod1 on muscle genes, while in
pro-B cells, Smad3 couples with PU.1 on lymphocyte-specific
genes (Figure 3A). These findings suggest that master transcrip-
tion factors expressed by stem cells and progenitors function by
priming key lineage-specific genes, which can then become
activated in response to canonical TGF-b superfamily signaling.
Since the abundance of cell-type-specific master transcription
Figure 3. Molecular Mechanisms of ESC Differentiation and
Lineage-Specific Roles of TGF-b Signaling
(A) In ESCs, activated pSmad2/3-Smad4 complexes are recruited by the
master regulator Oct4 to genes that maintain pluripotency. In myotubes and
Pro-B lymphocyte progenitors, activated Smad complexes are recruited by
different lineage-specific master regulators, MyoD and PU.1, respectively,
which are bound to lineage-specific genes governing muscle and B cell
differentiation.
(B) During mesendodermal fate specification of ESCs, signaling through
TGF-bs, Activins, and Nodal results in the generation of two distinct tran-
scriptional complexes: pSmad2/3-Smad4 and pSmad2/3-TRIM33. Expres-
sion of homeostatic genes, such as Smad7 and Skil, are mediated only by
pSmad2/3-Smad4. In contrast, master regulator genes of differentiation, such
as Gsc and Mixl1, exist in a transcriptionally poised state, as represented by
the presence not only of RNA polymerase II at the transcription start site, but
also the repressive histone modification H3K9me3 and its binding associate
HP1. In order to activate these poised genes, cooperative actions must occur
between pSmad2/3-TRIM33 and pSmad2/3-Smad4 and an additional tran-
scription cofactor, FoxH1. In some way, this elicits an active chromatin
conformation as revealed by histone acetyltransferase p300 and the added
acetylation mark at lysine 18 on H3.
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ultimately dominate the competition for interactions with
Smad2/3 (Young, 2011).
Genes that control master regulators of differentiation are
often maintained in a quiescent but ‘‘poised’’ state, which can
be rapidly transcribed in response to differentiation signals.
The promoters of twomaster regulator genes for early embryonic
development, goosecoid (Gsc) and Mixl1, contain poised
features, which include RNA polymerase II (Pol II) paused atthe transcription start site and kept from active transcription by
a chromatin compacting complex of H3K9me3 and HP1 (Fig-
ure 3B, left). Recently, the Massague´ group reported that in
response to Nodal/Activin signaling, pSmad2/3 forms a complex
with tripartite motif 33 (TRIM33, also known as TIF1g/ectoder-
min), previously identified as a TGF-b1-induced pSmad2/3
binding partner in hematopoietic stem cells (HSCs) (He et al.,
2006). In this case, pSmad2/3-TRIM33 complexes appeared to
translocate to the nucleus where they recognized histone marks,
displaced HP1, and allowed binding of Smad4-pSmad2/3 to
Activin Response Elements (AREs) within the Gsc and Mixl1
promoters (Xi et al., 2011). In turn, the complex recruited addi-
tional transcriptional regulators, further generating the requisite
active chromatin conformation and relieving Gsc and Mixl1
from their poised states (Figure 3B, right). By contrast, Activin/
Nodal regulated genes involved in essential cellular functions
and homeostasis do not exist in this poised state and conse-
quently responded to TGF-b signaling by either activating or re-
pressing their transcription. An additional point worthmentioning
is that TRIM33 depletion in mESCs markedly inhibited the
expression of mesendodermal, but not ectodermal, markers,
further consistent with the established role of Nodal/Activin in
mesendodermal fate specification.
While this model invoking TRIM33 is intriguing, studies by
Piccolo and colleagues suggest that TRIM33 binds to Smad4
and not Smad2/3, and that it functions as a ubiquitin ligase for
Smad4 (Dupont et al., 2005; Agricola et al., 2011). Moreover,
at least two other hypothetical models could explain Nodal/
Activin-induced triggering of ESC differentiation: the first is
through the crosstalk with Wnt signaling described above (Singh
et al., 2012), and the other is through physical interactions
between pSmad2/3-Smad4 and histone demethylase JMJD3/
KDM6B, resulting in a loss of H3K27me3 repressive marks in
Gsc and other Nodal/Activin target gene loci (Dahle et al.,
2010; Kim et al., 2011). Given the intensity of research in this
arena, the precise transcriptional governance of ESC differentia-
tion by signaling through TGF-b superfamily members will surely
continue to evolve.
TGF-b Superfamily Signaling in Tissue-Specific
Stem Cells
Most if not all adult tissues harbor resident stem cells that are
dedicated to life-long maintenance and wound repair. Some
are perpetually active, such as intestinal stem cells, while others
are more sparingly used, such as stem cells of hair follicles,
hematopoietic system, and mammary gland. Irrespective of
cycling behaviors, adult stem cells typically give rise to interme-
diate progenitors, sometimes referred to as ‘‘transit amplifying’’
(TA) cells, which then progress to differentiate to make functional
tissue. TGF-b superfamily members figure prominently in most if
not all of these steps, and broadly in most if not all tissues.
Studies in the past decade have begun to shed light on some
of the reasons why.
At high levels, TGF-bs often inhibit cell proliferation in a revers-
ible manner (Massague´, 2008). This raises particular intrigue for
the stem cell field, where many adult stem cells not only display
TGF-b receptors on their cell surface but also survive for months
in a quiescent state (Cotsarelis et al., 1990; Cheshier et al., 1999;
Tumbar et al., 2004). In contrast to senescence and terminalCell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc. 755
Figure 4. Diverse Functions of TGF-b Signaling in the Control of
Adult Stem Cell Behaviors
(A) The bone marrow niche consists of a variety of cell types, which include
hematopoietic stem cells (HSCs), mesenchymal stem cells, osteoblasts,
endothelial cells, CXCL12-abundant reticular (CAR) cells, sympathetic
neurons, and nonmyelinating Schwann cells. HSCs located on the endosteal
side of the niche tend to be quiescent, a feature necessary for their
self-renewal and maintenance of stemness, while HSCs residing on the
perivascular side are more active, priming them for differentiation. HSC
quiescence is dependent upon active TGF-b, which appears to be released
from its associated LAP through amechanism involving b8-integrin, expressed
on the surface of the nonmyelinated Schwann cells. TGF-b signaling also
exacerbates the functional differences between the myeloid and lymphoid
HSC subtypes. TGF-b enhancesMy-HSC self-renewal at low levels and drives
myeloid differentiation at higher levels. By contrast, even at low levels, TGF-
b induces Ly-HSC differentiation and inhibits their self-renewal.
(B) In the hair follicle, epithelial hair follicle stem cells (HFSCs) and melanocyte
stem cells (McSCs) are located in a niche referred to as the bulge and hair germ
(HG). Demarcating the dermis and epithelium is a basement membrane, and
although the dermis contributes to niche signaling, HFSCs are restricted to the
follicle side of the basement membrane. Sandwiched between the HFSC layer
and the club hair is a layer of inner bulge cells (red circles) that emit high levels
of BMP6 and FGF18 that maintain HFSC quiescence. Another key niche
component is a transient one, the dermal papilla (DP), which only sits at the
base of the bulge during the resting phase of the hair cycle, when HFSCs are in
their most quiescent state. During this phase, crosstalk between HFSCs and
DP changes their transcriptional states and ultimately leads to TGF-b2
production by the DP, and pSmad2/3-Smad4 signaling by the adjacent
HFSCs. A key downstream TGF-b2 signaling target is the gene encoding
Tmeff1, which inhibits BMP signaling and lowers the threshold necessary to
initiate HFSC self-renewal and fate specification necessary to launch a new
round of hair growth.
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in response to specific environmental cues. An ability of TGF-b
superfamily members to balance active proliferation and revers-
ible cell cycle exit may be important to maintain reservoirs of
stem cells that are able to respond quickly to changes in tissue
physiology.
Hematopoietic Stem Cells
Each day, billions of new blood cells are made to replace the
billions lost. This stream of fresh new cells in our blood originates
from multipotent HSCs, which give rise to all myeloid and
lymphoid lineages (Wang and Wagers, 2011). Adult HSCs reside
as rare cells in the bone marrow, where they sit atop a hierarchy
of progenitors that become progressively lineage restricted
(Zhang et al., 2003; Orkin and Zon, 2008). However, HSCs
show heterogeneous behavior at the clonal level (Lemischka
et al., 1986; Smith et al., 1991) and recent evidence suggests
that the hematopoietic system is actually maintained by a
consortium of functionally distinct HSC subtypes with different
self-renewal and differentiation potentials (Sieburg et al., 2006;
Dykstra et al., 2007).
Goodell and colleagues recently characterized two distinct
HSC subpopulations and discovered that they respond differ-
ently to TGF-b signaling (Challen et al., 2010). One subtype
was relatively quiescent, longer-lived, and biased toward differ-
entiating into myeloid lineages, while the other subtype was
more proliferative, shorter-lived, and biased toward lymphoid
differentiation. Each subtype was successful in long-term, multi-
lineage reconstitution of the entire blood system, and thus
merited HSC classification. Moreover, each population main-
tained inherent bias toward generating their designated hemato-
poietic branch in serial transplantations.
Interestingly, TGF-b exacerbated these functional differ-
ences in vitro and in vivo. At high levels, TGF-bs inhibited
proliferation of both myeloid-biased (My-) and lymphoid-biased
(Ly-) HSCs. However, at lower concentrations, TGF-bs stimu-
lated My-HSC but still impaired Ly-HSC proliferation in vitro,
and when recombinant TGF-b1 was administered to mice
during hematopoietic reconstitution in vivo, these differential
effects were recapitulated (Figure 4A). Although the exact
mechanisms underlying these distinct cellular responses to
TGF-b signaling are not yet known, the TGF-b-induced differ-
ences in behavior were accompanied by subtype-specific
differences in expression of the master regulators of myeloid
and lymphoid differentiation, namely PU.1 (granulocyte/macro-
phage lineage) and Ikaros (B and T cell lineage) (Challen et al.,
2010). In light of these new findings, it is intriguing that aging
HSCs have a myeloid-differentiation bias compared to their
young counterparts (Sudo et al., 2000; Kim et al., 2003). In
the future, it will be interesting to see if these age-related differ-
ences are rooted in local or systemic TGF-b production, and if
so, whether subtype balance might be restored by lowering
TGF-b levels.
TGF-b signaling has long been implicated in regulating HSC
quiescence (Fortunel et al., 2000; Yamazaki et al., 2009). In
part, TGF-bs seem to prevent HSC re-entry into the cell cycle
by upregulating transcription of the cyclin-dependent kinase
(CDK) inhibitor p57Kip2 and suppressing PI3K/Akt signaling (Ya-
mazaki et al., 2006). Niche cells in the bone marrow produce
latent TGF-b. Since HSCs cannot activate TGF-b by themselves
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active TGF-b exists in the HSC niche.
Recently, Nakauchi and colleagues used antibodies specific
to the latent and active TGF-b forms to reveal that the nonmyeli-
nating Schwann cells ensheathing sympathetic nerves in bone
marrow are responsible for activation (Yamazaki et al., 2011).
Although many details of the pathway remain to be determined,
integrins avb8 expressed by Schwann cells most likely facilitate
proteolytic degradation of the latent peptide by activating matrix
metalloproteinases (Mu et al., 2002; Annes et al., 2003). To
ascertain how TGF-b controls HSC quiescence, the authors
generated lymphocyte-deficient, TbRII conditional knockout
mice and infused bonemarrow cells from thesemice into lethally
irradiated recipients (Yamazaki et al., 2011). HSCs lacking TbRII
showed reduced pSmad2/3, increased cycling, and reduced
long-term repopulating activity in HSCs. Indeed, the contribution
of TbRII-deficient HSCs to peripheral blood myeloid cells gradu-
ally declined over time. Furthermore, when nonmyelinating
Schwann cells in bone marrow were depleted by denervation
of sympathetic nerves and then used as recipients in repopula-
tion analyses, pSmad2/3 was reduced in HSCs and their overall
numbers declined. The ability to convert the latent form of TGF-b
to its active state adds to the multiplicity of ways in which niche
cells might control quiescence of their stem cells (Figure 4A).
By studying the zebrafish hematopoietic system, the Zon
group recently showed that, analogous to ESCs, HSCs utilize
both BMP and Wnt signaling to regulate lineage selection and
differentiation (Trompouki et al., 2011). Moreover, in responding
to these signaling cues, HSCs apply many of the transcriptional
paradigms used by ESCs. Thus, Smad1 and Tcf3 selectively co-
occupied at enhancer elements of HSC lineage-distinctive genes
in concert with cell-type-specific master regulators: GATA1 for
the erythroid lineage and C/EBPa, which often cofunctions
with PU.1, for the myeloid lineage. In addition, signaling greatly
enhanced activation of these blood-cell-type-specific enhancer
elements, most likely through recruitment of p300 histone acetyl-
transferase. Moreover, at the start of hematopoietic regenera-
tion, BMP and Wnt signaling resulted in colocalization of
Smad1 and Tcf3 to master regulator-bound genes that define
progenitor cell fate. As regeneration continued and progenitor
cells began to differentiate, different master regulators redir-
ected Smad1 and Tcf3 to genes expressed at more mature
hematopoietic stages (Trompouki et al., 2011).
Hair Follicle Stem Cells
In adult mice, hair follicles undergo dynamic, synchronized bouts
of growth (anagen), degeneration (catagen), and rest (telogen).
During the resting phase, which can last for months, epithelial
hair follicle stem cells (HFSCs) are quiescent and reside in
a niche, referred to as the bulge (Fuchs, 2007). The single layer
of polarized bulge HFSCs is sandwiched between an outer base-
ment membrane and an inner layer of keratin-6-expressing,
differentiated cells that anchor the old hair (Hsu et al., 2011). A
small cluster of ‘‘primed’’ HFSCs (the hair germ, HG), reside at
the bulge base and will be the first progenitors activated at the
start of each new hair cycle. The HG directly overlies the dermal
papilla (DP), which serves as the essential mesenchymal
signaling center for HFSCs (Cotsarelis et al., 1990). Adding to
the complexity of the bulge stem cell niche are smooth muscle
fibers (Fujiwara et al., 2011), sensory neurons (Brownell et al.,2011), adipocytes (Festa et al., 2011), blood vessels, and
a sheath of dermal fibroblasts. A small number of melanocyte
stem cells (McSCs) also reside in the bulge, particularly in the
HG, and coordinate their quiescence, activation, and lineage
commitments with the HFSCs (Nishimura et al., 2002).
Throughout the resting phase, HFSC quiescence is main-
tained in part by BMPs provided from the inner layer of non-
stem niche cells (Hsu et al., 2011) and from surrounding dermal
fibroblasts and adipocytes (Plikus et al., 2008). When the
Bmpr1a gene is conditionally ablated during the resting phase,
HFSCs become active and overproduce, and tumor-like struc-
tures form from the bulge (Zhang et al., 2006; Kobielak et al.,
2007). Thus in the normal niche, BMP signaling must be tran-
siently lowered in order to activate proliferation and lineage
commitment in a small number of HFSCs, but then it must be
elevated again to enable the niche to restore quiescence within
its residents. BMP signaling also functions in the TA cells of
the follicle, but in this case, elevated signaling is associated
with terminal differentiation (Kobielak et al., 2003).
The hair cycle is fueled by epithelial-mesenchymal crosstalk
that takes place at the base of the bulge stem cell niche during
the resting phase. It culminates in the accumulation of the neces-
sary threshold of activating factors to transition the stem cells
to begin a new round of hair growth (Greco et al., 2009). The
process involves Wnt-activating cues (Merrill et al., 2001;
Enshell-Seijffers et al., 2010; Rabbani et al., 2011) as well as
BMP inhibitory factors (Kulessa et al., 2000; Botchkarev et al.,
2001; Zhang et al., 2006). Many of these factors, including
Rspo1/2 (Wnt-activating) and Sostdc1 (BMP-inhibitory), are
made by the DP (Greco et al., 2009).
Recently, we uncovered an additional player, TGF-b2, which is
primarily produced by DP but triggers signaling and nuclear
pSmad2 in the overlying HG cells just prior to their activation
(Oshimori and Fuchs, 2012). Unexpectedly, TGF-b signaling
appeared to stimulate HFSC proliferation by counteracting
quiescence in the niche. Moreover, TbRII-deficient HFSCs dis-
played elevated pSmad1 and BMP signaling and delayed hair
cycle entry. Interestingly, the antagonistic effects of TGF-b
signaling on BMP signaling appeared to be rooted in at least
one underlying target gene, Tmeff1, which was previously shown
to block BMP2-mediated mesoderm induction in Xenopus
embryos (Chang et al., 2003). Tmeff1 is normally upregulated
concomitant with TGF-b2 signaling and inhibition of BMP
signaling in activated HG progenitors (Oshimori and Fuchs,
2012). In TbRII mutant progenitors, Tmeff1 was diminished,
and when Tmeff1 was knocked down in wild-type HFSCs,
TGF-b2’s suppression of BMP signaling was abrogated, and
hair follicle regeneration was significantly delayed (Figure 4B).
Finally, Tmeff1 diminished the response of wild-type HFSCs to
BMP signaling in vitro, in a fashion similar to that of TGF-b2.
Similar to the effects of TGF-bs observed for My-HSCs
(Challen et al., 2010), HFSCs were stimulated by low concentra-
tions of TGF-b2 both in vivo and in vitro, but higher concentra-
tions resulted in cell cycle arrest (Oshimori and Fuchs, 2012).
In the future, it will be interesting to see the extent to which the
opposing stem cell behaviors elicited by different TGF-b levels
arise from the antagonizing effects that TGF-b signaling can
have on BMP signaling, and whether additional antagonistic
effects will emerge between other members of the TGF-bCell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc. 757
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respond similarly to TGF-b signaling, since for Ly-HSCs, TGF-bs
even at low levels showed growth inhibition (Challen et al., 2010).
Similarly in the hair follicle, niche-derived TGF-b signaling
appears to function in McSC quiescence, and loss of TbRII in
McSCs results in their ectopic activation and differentiation
(Nishimura et al., 2010), which does not happen when TbRII is
targeted in HFSCs (Oshimori and Fuchs, 2012).
An additional note in comparing HFSCs and HSCs is that
analogous to HSCs, a handful of key transcription factors and
epigenetic regulators have been shown to function as master
regulators of HFSC renewal and maintenance (Blanpain and
Fuchs, 2009; Lien et al., 2011; Chen et al., 2012b). Although
a few of the factors, e.g., Lhx2, are expressed by both HSCs
and HFSCs, most are not, suggesting that the main role of
master regulators in stem cells is to govern lineage-specific
programs rather than universal features of stemness. Moreover,
although the diverse roles of BMPs, Wnts, and TGF-bs in acti-
vating tissue-specific lineage programs in stem cells is in agree-
ment with the ability of their transcriptional effectors to interact
with these tissue-specific master regulators, their significantly
broader expression among stem cells renders them candidates
for regulating general stem cell features as well.
Lessons Learned from Studying TGF-b Superfamily
Signaling in Other Adult Stem Cell Populations
Comprehensive coverage of TGF-b superfamily signaling in all
adult stem cells is beyond the scope of the current review.
However, in addition to reinforcing many of the paradigms dis-
cussed thus far, some intriguing new twists on these signaling
networks have emerged from other systems. Here, we highlight
just a few of the many lessons learned from studying TGF-b
signaling in other adult stem cell populations.
Neural Stem Cells
The central nervous system develops from self-renewing, multi-
potent neuroepithelial cells that give rise to neural progenitor
cells and eventually to neurons, astrocytes, and oligodendro-
cytes. The choice between self-renewal versus differentiation
of neuroepithelial cells determines growth and size of the devel-
oping brain (Go¨tz andHuttner, 2005). As inmany stem cells,Wnt/
b-catenin signaling promotes cell-cycle progression of neuroepi-
thelial cells (Chenn and Walsh, 2002). Recently, Sommer and
colleagues showed that TGF-b signaling controls brain size by
antagonizing canonical Wnt signaling and negatively regulating
neuroepithelial cell self-renewal (Falk et al., 2008).
Neurogenesis continues throughout adult life, and is fueled by
at least two specialized neural stem cell (NSC) niches: the sub-
ventricular zone (SVZ) of the lateral ventricles and the subgranu-
lar zone (SGZ) of the hippocampal dentate gyrus (Zhao et al.,
2008). In the SGZ, quiescent NSCs (Sox2+ radial cells) coexist
with their progenitors (Sox2+ nonradial cells). Recently, Gage
and colleagues found that quiescent NSCs express ALK3/
BMPR1A, while their progeny express ALK6/BMPR1B (Mira
et al., 2010). Although pSmad1 was detected in both NSCs
and progenitors, BMP signaling was transiently inhibited in
NSCs undergoing proliferation. Moreover, when BMP signaling
was blocked in the brain niche, NSCs initially proliferated, but
this eventually waned. Interestingly, even though the number of
progenitors diminished, the number of NSCs remained constant.758 Cell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc.These observations are compatible with a model in which the
production of progenitors by asymmetrically dividing NSCs
becomes compromised after a certain number of mitotic rounds,
resembling NSC behavior in aged hippocampus (Hattiangady
and Shetty, 2008). Taken together, these findings argue
that canonical BMP signaling downstream of ALK3/BMPR1A
regulates NSC quiescence, which is required to support contin-
uous neurogenesis throughout adult life. It will be interesting
in the future to identify the source of BMP ligands and antago-
nists in the brain, and to elucidate the significance of using
different BMP receptors (BMPR1A and BMPR1B) during normal
homeostasis.
Skeletal Muscle Stem Cells
Skeletal muscle development, growth, and regeneration rely on
muscle stem cells (MuSCs). Fetal myogenesis is important for
the growth and maturation of muscles. Duprez and colleagues
recently revealed that BMP4 signals from emerging tendons
impact the behavior of a subpopulation of dividing MuSCs at
the tips of fetal skeletal muscle (Wang et al., 2010). In contrast
to NSCs, enhanced BMP signaling via ALK3/BMPR1A seemed
to promote MuSC proliferation, as judged by increased numbers
of fetal MuSCs and muscle fibers. Conversely, blocking BMP
signaling resulted in fewer MuSCs. When taken together with
the markedly elevated BMP expression by tendons, these
results are consistent with prior observations noting increased
satellite (MuSC) cell proliferation at sites close to tendons (Tsuji-
mura et al., 2006), and longitudinal growth at the ends of skeletal
muscle fibers (Williams and Goldspink, 1971).
In the adult, quiescent MuSCs reside between muscle fibers
and surrounding basement membrane. Upon muscle damage,
quiescent MuSCs begin proliferating, differentiate into myo-
blasts, and fuse to form de novo multinucleated myofibers
(Collins et al., 2005). However, as the muscle ages, its ability to
regenerate diminishes and eventually fails. It has been sug-
gested that the age-related decline inmuscle tissue regeneration
may result from diminished activation of Notch pathway, which
is known to antagonize Wnt signaling and enable MuSCs to
proliferate (Conboy et al., 2003; Brack et al., 2007).
Recently, Conboy and colleagues found that factors secreted
by aged myofibers result in higher levels of TGF-b and nuclear
pSmad3 signaling in MuSCs, whether old or young (Carlson
et al., 2008). These tantalizing findings prompt the speculation
that with age, signaling activity in the MuSC niche shifts from
active Notch to active TGF-b/pSmad3. Consistent with this
notion, endogenous Notch and pSmad3 have opposing effects
on MuSC proliferation. Through mechanisms not fully under-
stood, active Notch reduces pSmad3 occupancy on key
TGF-b-dependent target genes, such as CDK inhibitors (Carlson
et al., 2008). To this end, attenuation of canonical TGF-b signaling
in old, injured muscle restores MuSC activity in vivo. These find-
ings provide compelling evidence that this age-specific interplay
between active Notch and TGF-b/pSmad3 signaling controls
CDK inhibitor levels in MuSCs and in turn governs tissue regen-
erative capacity upon muscle injury.
Recently, synergistic crosstalk between Notch and TGF-b
signaling was also discovered in prostate epithelial homeostasis
(Valdez et al., 2012). In prostate basal stem/progenitor cells,
Notch appears to serve not only as a downstream effector but
also an amplifier for the TGF-b-induced cytostatic program.
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Alterations in bone remodeling occur in many human bone
diseases. The normal adult bone undergoes continual remodel-
ing by precisely coordinating the activities of osteoblasts, which
deposit the calcified bone matrix, and osteoclasts, which resorb
bone (Zaidi, 2007). Factors released from bone matrix during
osteoclastic bone resorption are thought to orchestrate migra-
tion of mesenchymal stem cells (MSCs) to the resorptive
surfaces of the bone. Cao and colleagues demonstrated that
osteoclastic bone resorption releases stored TGF-b1, which
recruits boneMSCs to active sites of remodeling through canon-
ical pSmad signaling (Tang et al., 2009). Interestingly, either
overactivation or inhibition of TGF-b signaling caused significant
reductions in MSCs at bone remodeling surfaces. Moreover,
hyperactivation of TGF-b signaling uncoupled bone resorption
and formation processes. Probing into mechanism, local
TGF-b1 levels appear to determine how many bone MSCs will
be recruited to resorptive sites, which secrete osteotropic
factors such as BMPs, IGFs, and PDGFs that promote MSC
differentiation into osteoblasts.
Cancer Stem Cells
Cancers develop from normal cells that eventually gain the ability
to proliferate aberrantly and become malignant. Many of the
mutations leading to cancer affect signaling pathways involving
TGF-b superfamily members (Bierie and Moses, 2006; Mas-
sague´, 2008). In addition, for cancers arising in individuals who
are not genetically at high risk, tissue-specific stem cells may
be preferential targets for initial oncogenic mutations, because
they are long-lived and hence have time to accumulate the
myriad of mutations that will ultimately lead to cancer (Lobo
et al., 2007). Cancer stem cells (CSCs) are cells within a cancer
that have the capacity to be serially transplanted at the single
cell level and initiate new cancers with characteristics of the
parental tumor. The concept of CSCs reveals a new framework
of cancer therapeutic strategies (Clevers, 2011). CSCs have
been identified in a number of different cancers of both hemato-
poietic and solid tissue lineages (Driessens et al., 2012;
Schepers et al., 2012; Chen et al., 2012a).
Schober and Fuchs recently identified and characterized
CSCs purified from the tumor-stroma interface in a number of
malignant squamous cell carcinomas (SCCs) (Schober and
Fuchs, 2011). The SCCs investigated included those whose
skin epithelium is compromised for TGF-b signaling and which
showed enhanced integrin/focal adhesion kinase (FAK) signaling
and tumor susceptibility (Guasch et al., 2007), and those which
lack integrin/FAK signaling and exhibit increased levels of tumor
regression (McLean et al., 2004). TbRII null CSCs formed highly
aggressive, less differentiated SCCs, and exhibited a dramatic
increase in the ability to initiate secondary tumor formation.
Surprisingly, these phenotypes were almost completely com-
promised in CSCs from SCCs lacking both TbRII and FAK
(Schober and Fuchs, 2011). Thus, CSC proliferation and expan-
sion at the tumor-stroma interface where TGF-b and integrin/
FAK signaling intersect is dependent upon the extent to which
CSCs can respond to stromal TGF-b1 and counterbalance the
elevated integrin/FAK signaling that otherwise occurs during
malignant transformation.
Chronic myeloid leukemia (CML) is a cancer of white blood
cells caused by a constitutively active tyrosine kinase, BCR-ABL. It is typified by clonal expansion of HSCs. Although treat-
ments with tyrosine kinase inhibitors dramatically improve
survival rate, leukemia-initiating cells (LICs) can escape treat-
ments and drive CML recurrence. In CML cell lines, BCR-ABL
activates PI3K/Akt signaling, leading to nuclear export and
diminished activity of Foxo transcription factors. If Akt phosphor-
ylation is suppressed in LICs, Foxo3a becomes nuclear, a feature
that correlates with long-term maintenance, survival, and malig-
nant potential of LICs (Naka et al., 2010). As in normal HSCs
(Yamazaki et al., 2006), TGF-b selectively inhibits Akt activation
and facilitates nuclear Foxo3a in CML LICs, but not non-LICs,
underscoring the possible therapeutic importance of small mole-
cule inhibitors of TGF-b signaling. Indeed, in mouse CML
models, the TbRI inhibitor Ly364947 combined with the tyrosine
kinase inhibitor imatinib significantly reduced recipent lethality
and decreased CML infiltration in lung, suggesting that CML
LICs are even more sensitive than normal HSCs to TGF-b inhibi-
tors (Naka et al., 2010).
Agonistic effects of TGF-b signaling are also found in malig-
nant gliomas, where TGF-b works as an oncogenic factor and
is also considered a therapeutic target (Akhurst, 2006; Seoane,
2008). Indeed, when patient-derived gliomas are dissociated
into single cells and cultured, TGF-b enhanced the number and
size of neurospheres, suggesting that TGF-b signaling increased
self-renewal in glioma initiating cells (GICs) (Pen˜uelas et al.,
2009). Interestingly in this case, the effects of TGF-bs on GIC
self-renewal were traced to the LIF/STAT signaling pathway,
and the gene encoding LIF appeared to be a direct pSmad2/
3-Smad4 target. Moreover, TGF-b did not induce LIF or increase
the self-renewal capacity of normal NSCs, again underscoring
the striking differences in how TGF-bs effect self-renewal in
normal versus CSCs. Miyazono and colleagues also demon-
strated that glioma cells produce autocrine TGF-b signaling
and that TGF-b-Sox4-Sox2 pathway is important for mainte-
nance of stemness of GICs (Ikushima et al., 2009). BMP has
also been reported to be involved in both suppression and
promotion of GIC tumorigenicity (Piccirillo et al., 2006; Lee
et al., 2008).
The agonistic effects of TGF-bs on CSCs of leukemias and
gliomas are in stark contrast to the antagonistic effects of
TGF-bs on CSCs from squamous cell carcinomas. The ability
of different CSCs to respond differently to TGF-bs underscores
the potential dangers in using TGF-b agonists or antagonists in
the clinic. In addition, even for a single stem cell type, TGF-bs
can have dual roles in oncogenesis. Thus in many normal and
premalignant cells, TGF-b enforces homeostasis and sup-
presses tumor progression either directly, through cell-autono-
mous tumor-suppressive effects, or indirectly, through effects
on the stroma. However, when cancer cells lose TGF-b tumor-
suppressive responses, they can use TGF-bs to their advantage
to initiate immune evasion, produce growth factors, transform
into an invasive phenotype, and metastasize to establish and
expand elsewhere in the body (Massague´, 2008).
In addition to cell proliferation control of tumor cells and CSCs,
TGF-bs also play distinct roles in epithelial-mesenchymal transi-
tions (EMTs). EMTs affect critical steps of morphogenesis by
interconverting epithelial cell types into cells with mesenchymal
attributes, allowing polarized cells of an epithelial sheet to
delaminate, assume a spindle-like mesenchymal shape, migrateCell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc. 759
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et al., 2009). In addition, some epithelial cells that pass through
an EMT acquire self-renewing traits typical of stem cells (Mani
et al., 2008), and when activated in carcinoma cells, EMTs
can lead to metastasis and high-grade malignancy (Yang and
Weinberg, 2008). Interestingly, immortalized human mammary
epithelial cells with mesenchymal features display autocrine
TGF-b1 as well as canonical and noncanonical Wnt signaling
(Scheel et al., 2011). In vitro, these signaling pathways coopera-
tively enhance mammosphere formation and other stemness
characteristics, and upon Ras-oncogenic transformation and
transplantation, signs of increased tumor-initiation and metas-
tasis emerge. In some cell types, BMP signaling has been found
to antagonize TGF-b1-driven EMTs (Zeisberg et al., 2003),
providing another example of mutual antagonism between the
TGF-b and BMP branches of superfamily signaling.
Conclusions and Perspectives
A decade ago, it was becoming increasingly clear that most if not
all adult tissues have stem cells. A stream of new insights have
followed, shedding light on how stem cells decide when to
make tissue, when to stop making it, and when to self-renew.
At the helm of these decisions is the intricate balance between
proliferation and cell fate signals that stem cells receive from
their niche microenvironments. Not surprisingly, the TGF-b
superfamily features prominently in making the choice, often in
consultation with other intersecting pathways, e.g., Wnts and
receptor tyrosine kinases. But each stem cell niche is different.
Thus, even though every stem cell may be endowed with recep-
tors that enable them to respond to TGF-bs/Nodal, BMPs, Wnts,
and growth factors, their responses often differ, in part because
of intrinsic differences established during the course of develop-
ment, and in part because the particular constellation of
extracellular cues within each niche is distinct. When coupled
with the ability of TGF-b and BMP branches of the superfamily
to antagonize each other as well as intersect with and influence
receptor tyrosine kinase and Wnt pathways, even subtle differ-
ences, perhaps only in signal doses, can have profound effects.
While the complexities underlying TGF-b superfamily regula-
tion of stem cell behavior may seem daunting, sifting through
the biochemical mechanisms has been aided by recent
advances in genome-wide analyses of Smad binding to chro-
matin. Major new insights have come from the finding that the
choice of genes to be regulated by pSmad2/3-Smad4 is guided
by the master regulators expressed by a particular stem cell
lineage. Similar findings have come for Tcf3, a key component
in the Wnt pathway, suggesting that this paradigm may hold
for other signaling pathways that control stem cell behavior
and fate commitment. Indeed, when coupled with sequence
and context-specific differences in pR-Smad-Smad4 binding
to its targets, this model could explain not only how stem cells
receive and translate different dosages and combinations of
extracellular cues, but also how a particular signaling pathway
perceives the temporal lineage of a tissue-specific stem cell,
and why a cell’s life history matters. The concept may be espe-
cially pertinent in explaining why stem/progenitor cells at distinct
developmental stages may respond differently to a collection of
extracellular cues. Moreover, given that new master regulators
may themselves be targets of a signaling pathway, it begins to760 Cell Stem Cell 11, December 7, 2012 ª2012 Elsevier Inc.show why the order in which a cell receives a series of signals
often matters critically. In this regard, spatial and temporal
profiling of signaling at the single-cell level, by, for example,
the reporter system we used (Oshimori and Fuchs, 2012), will
help us to understand the complex mechanisms of TGF-b.
As we emphasized in this review, new levels of regulation
within the TGF-b superfamily continue to emerge, and with
them come new appreciations for the questions still unanswered
and areas remaining to be explored. While we have learned that
the strength of TGF-b superfamily signaling often dictates cell
fate, it is not clear how different signaling levels are sensed by
different stem cells and how this is impacted by their niche.
How does signaling dosage impact R-Smad-Smad4 target
gene selection and/or expression? Similarly, the sources and
cells responsible for activation of TGF-b ligands have helped to
provide new insights into their roles in governing the stem cell
niche, but our knowledge on TGF-b ligand bioavailability is still
limited. How broadly are mechanisms of latency and ligand
activation utilized in biology? Are they operative in stem cell
niches, and if so, which niches and under what circumstances?
Another intriguing facet of TGF-b signaling is the existence of
noncanonical signaling among the TGF-b superfamily. How
broadly are such mechanisms used by different superfamily
members, and under what occasions? Do switches in canonical
and noncanonical TGF-b superfamily signaling pathways func-
tion in regulating the balance between self-renewal and fate
commitment? Thus in addition to the tremendous advances
made in our knowledge of stem cells and TGF-b superfamily
signaling, there are many exciting and fascinating discoveries
awaiting the field in the decade to come. Given that stem cells
and TGF-b signaling stand precariously at the intersection
between normal tissue biology and cancer, the new insights
waiting to be gained will no doubt find their way to clinical appli-
cations.
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